texmeten universal cream 0.1% (テクスメテンユニバーサルクリーム0.1%)
sato pharmaceutical co.,ltd - diflucortolone valerate - white to faintly yellowish white creamy ointment
texmeten ointment 0.1% (テクスメテン軟膏0.1%)
sato pharmaceutical co.,ltd - diflucortolone valerate - white to faintly yellowish white ointment
teveten eprosartan 600mg (as mesilate) tablet blister pack
viatris pty ltd - eprosartan mesilate, quantity: 735.8 mg (equivalent: eprosartan, qty 600 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; pregelatinised maize starch; hypromellose; macrogol 400; polysorbate 80; titanium dioxide - teveten is indicated for the treatment of essential hypertension.
teveten eprosartan 400mg (as mesilate) tablet blister pack
viatris pty ltd - eprosartan mesilate, quantity: 400 mg (equivalent: eprosartan mesilate, qty 400 mg) - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400 - teveten is indicated for the treatment of essential hypertension.
teveten plus 600/12.5 eprosartan 600mg/hydrochlorothiazide 12.5mg tablet blister pack
viatris pty ltd - hydrochlorothiazide, quantity: 12.5 mg; eprosartan mesilate, quantity: 735.8 mg (equivalent: eprosartan, qty 600 mg) - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; pregelatinised maize starch; titanium dioxide; iron oxide yellow; purified talc; polyvinyl alcohol; iron oxide black; macrogol 3350 - teveten plus is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.
teveten hct- eprosartan mesylate and hydrochlorothiazide tablet
physicians total care, inc. - eprosartan mesylate (unii: 8n2l1nx8s3) (eprosartan - unii:2kh13z0s0y), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - eprosartan 600 mg - teveten® hct is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensives such as calcium channel blockers. this fixed dose combination is not indicated for initial therapy (see dosage and administration ). teveten® hct is contraindicated in patients who are hypersensitive to this product or any of its components. because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs.
teveten plus 600/12.5 milligram film coated tablet
bgp products ltd - eprosartan mesylate, hydrochlorothiazide - film coated tablet - 600/12.5 milligram - eposartan and diuretics - angiotensin-ii antagonists, plain c - essential hypertension it is indicated in patients whose blood pressure is not adequately controlled on eprosartan alone.
teveten
abbott australasia pty ltd - eprosartan; eprosartan mesylate -
teveten plus
abbott australasia pty ltd - eprosartan; hydrochlorothiazide -
teveten plus 600/12.5 milligram film coated tablet
abbott healthcare products ltd - eprosartan mesylate hydrochlorothiazide - film coated tablet - 600/12.5 milligram